Legislation Aims to Prevent Pharma From Price-gouging During Pandemic
June 24, 2020
Two new bipartisan bills introduced by House Democrats aim to prevent the pharmaceutical industry from engaging in price-gouging on COVID-19 treatments, according to a Common Dreams report.
The legislation was introduced following a recent poll that found a whopping 88 percent of Americans fear the industry will exploit the pandemic to increase drug prices.
“This is about way more than ensuring taxpayers aren’t ripped off, as important as that objective is,” Public Citizen President Robert Weissman said in a statement supporting the bills. “Promoting transparency and reasonable pricing of Covid-19 treatments and vaccines is a life-and-death matter.”
To read the full report on Common Dreams, click here.
